Gagnon Advisors, LLC Care Dx, Inc. Transaction History
Gagnon Advisors, LLC
- $113 Million
- Q1 2024
A detailed history of Gagnon Advisors, LLC transactions in Care Dx, Inc. stock. As of the latest transaction made, Gagnon Advisors, LLC holds 610,336 shares of CDNA stock, worth $9.48 Million. This represents 5.7% of its overall portfolio holdings.
Number of Shares
610,336
Previous 554,851
10.0%
Holding current value
$9.48 Million
Previous $6.66 Million
2.93%
% of portfolio
5.7%
Previous 5.84%
Shares
15 transactions
Others Institutions Holding CDNA
# of Institutions
150Shares Held
55.1MCall Options Held
85.8KPut Options Held
48.8K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl5.86MShares$91.1 Million0.44% of portfolio
-
Black Rock Inc. New York, NY5.43MShares$84.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.3MShares$66.8 Million0.0% of portfolio
-
State Street Corp Boston, MA4.2MShares$65.2 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.93MShares$61.1 Million0.65% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $830M
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...